|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5728553A
(en)
*
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
DE19538625C2
(de)
*
|
1995-10-17 |
1999-08-12 |
Sartorius Gmbh |
Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
|
|
GB9526733D0
(en)
*
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
US6150133A
(en)
*
|
1996-03-13 |
2000-11-21 |
Delta Biotechnology Limited |
Fermentation control
|
|
GB9902000D0
(en)
*
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
|
AU2007200859A1
(en)
*
|
1999-01-30 |
2007-03-22 |
Novozymes Delta Limited |
Process
|
|
FR2792650B1
(fr)
*
|
1999-04-20 |
2003-02-28 |
Oreal |
Equivalent de peau agee, son procede de preparation et son utilisation
|
|
US8632785B2
(en)
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
ATE519494T1
(de)
*
|
2000-02-08 |
2011-08-15 |
Allergan Inc |
Pharmazeutische zusammensetzungen mit botulinum- toxin
|
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
EP2206720A1
(en)
|
2000-04-12 |
2010-07-14 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2002011676A2
(en)
|
2000-08-04 |
2002-02-14 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
|
DE60121196T2
(de)
*
|
2000-10-24 |
2007-07-12 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Verfahren zur monomerisierung von humanen serumalbumin-polymeren
|
|
JP4798832B2
(ja)
*
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
ヒト血清アルブミン多量体の除去方法
|
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20030036637A1
(en)
*
|
2001-06-13 |
2003-02-20 |
Scott Fulton |
Purification of human serum albumin
|
|
ITBO20010426A1
(it)
*
|
2001-07-06 |
2003-01-06 |
Alfa Wassermann Spa |
Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
|
|
JP2003040798A
(ja)
*
|
2001-07-26 |
2003-02-13 |
Nihon Pharmaceutical Co Ltd |
低アルミニウム含有アルブミン製剤およびその製造法
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
WO2003059884A1
(en)
*
|
2001-12-21 |
2003-07-24 |
X-Ceptor Therapeutics, Inc. |
Modulators of lxr
|
|
EP2261250B1
(en)
*
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
|
US20080167238A1
(en)
*
|
2001-12-21 |
2008-07-10 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
|
AU2002364587A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
|
NZ539735A
(en)
*
|
2002-10-02 |
2009-07-31 |
Dmi Biosciences Inc |
Diagnosis and monitoring of diseases using markers, such as diketopiperazines
|
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP1622633B1
(en)
|
2003-05-15 |
2016-02-24 |
Ampio Pharmaceuticals, Inc. |
Treatment of t-cell mediated diseases
|
|
US8013611B2
(en)
*
|
2006-07-14 |
2011-09-06 |
Reserve Power Cell, Llc |
Vehicle battery product and battery monitoring system
|
|
US7339347B2
(en)
*
|
2003-08-11 |
2008-03-04 |
Reserve Power Cell, Llc |
Apparatus and method for reliably supplying electrical energy to an electrical system
|
|
GB0329681D0
(en)
*
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
|
GB0329722D0
(en)
*
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
|
BRPI0418304A
(pt)
*
|
2004-01-07 |
2007-05-02 |
Trimeris Inc |
peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv
|
|
JP4644604B2
(ja)
|
2004-01-20 |
2011-03-02 |
一般財団法人化学及血清療法研究所 |
２価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
|
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
DK2330200T3
(en)
*
|
2004-12-23 |
2017-07-24 |
Albumedix As |
GENE EXPRESSION TECHNIQUE
|
|
CA2599731A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Dmi Biosciences, Inc. |
Quantification of proteins
|
|
US7598700B2
(en)
*
|
2005-03-30 |
2009-10-06 |
Reserve Power Cell, Llc |
Tamper resistant battery and battery warranty and performance tracking system
|
|
MY144344A
(en)
*
|
2005-04-08 |
2011-09-15 |
Ciba Holding Inc |
Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials
|
|
DE102005023155A1
(de)
|
2005-05-13 |
2006-11-16 |
Albutec Gmbh |
Albuminlösung
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
GB0518460D0
(en)
*
|
2005-09-09 |
2005-10-19 |
Univ Nottingham Trent |
Protein assay
|
|
US7456251B2
(en)
|
2006-02-02 |
2008-11-25 |
Trimeris, Inc. |
HIV fusion inhibitor peptides with improved biological properties
|
|
JP2007284425A
(ja)
*
|
2006-03-20 |
2007-11-01 |
Nokodai Tlo Kk |
タンパク質の精製方法
|
|
US8334365B2
(en)
*
|
2006-06-07 |
2012-12-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP2049560B1
(en)
*
|
2006-07-13 |
2013-05-15 |
Novozymes Biopharma DK A/S |
Process for preparing particles of proteinaceous material
|
|
WO2008012629A2
(en)
|
2006-07-24 |
2008-01-31 |
Biorexis Pharmaceutical Corporation |
Exendin fusion proteins
|
|
US10829733B2
(en)
*
|
2007-01-04 |
2020-11-10 |
Biolamina Ab |
Composition and method for enabling proliferation of pluripotent human stem cells
|
|
BRPI0809995A2
(pt)
*
|
2007-04-03 |
2015-07-21 |
Trimeris Inc |
Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
|
|
CN101104635B
(zh)
*
|
2007-04-30 |
2010-11-03 |
北京济普霖生物技术有限公司 |
一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法
|
|
CN101835801B
(zh)
*
|
2007-08-08 |
2014-09-10 |
诺维信生物制药丹麦公司 |
转铁蛋白变体和偶联物
|
|
KR20100080812A
(ko)
*
|
2007-09-25 |
2010-07-12 |
트라이머리스, 인코퍼레이티드 |
치료용 항-ｈｉｖ 펩티드의 합성 방법
|
|
CN101978268B
(zh)
*
|
2008-03-31 |
2014-04-23 |
积水医疗株式会社 |
纯化血清白蛋白及免疫学测定方法
|
|
CN102026648A
(zh)
*
|
2008-05-15 |
2011-04-20 |
株式会社·R-技术上野 |
用于治疗干眼和/或角膜结膜损伤的药物组合物
|
|
EP2300011A4
(en)
|
2008-05-27 |
2012-06-20 |
Dmi Life Sciences Inc |
THERAPEUTIC PROCESSES AND COMPOUNDS
|
|
JP5711118B2
(ja)
|
2008-06-24 |
2015-04-30 |
テクニッシュ ウニヴェルジテート ミュンヘン |
所与の標的に対してアフィニティーを有するｈＮＧＡＬおよび類縁タンパク質のムテイン
|
|
KR101722961B1
(ko)
|
2009-02-11 |
2017-04-04 |
알부메딕스 에이/에스 |
알부민 변이체 및 접합체
|
|
CA2752729A1
(en)
*
|
2009-02-20 |
2010-08-26 |
Ventria Bioscience |
Cell culture media containing combinations of proteins
|
|
DE102009013914B4
(de)
*
|
2009-03-19 |
2011-05-05 |
Bruker Daltonik Gmbh |
Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
|
|
DK2427486T3
(en)
*
|
2009-05-07 |
2015-05-26 |
Novozymes Biopharma Dk As |
A process for purifying albumin
|
|
JP2013501033A
(ja)
|
2009-08-05 |
2013-01-10 |
ピエリス アーゲー |
リポカリン突然変異タンパク質の制御放出製剤
|
|
AU2010284116B9
(en)
*
|
2009-08-20 |
2015-03-26 |
Takeda Pharmaceutical Company Limited |
Purification of VWF for increased removal of non-lipid enveloped viruses
|
|
CA2776241A1
(en)
|
2009-10-30 |
2011-05-05 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
|
BR112012013662B1
(pt)
|
2009-12-07 |
2022-08-02 |
Pieris Pharmaceuticals Gmbh |
Muteínas de lipocalina associada à gelatinase de neutrófilo humano (lcn2, hngal), seu uso e seus métodos de geração e produção, molécula de ácido nucleico, célula hospedeira, composição farmacêutica e kit de diagnóstico ou analítico
|
|
JP2013517776A
(ja)
*
|
2010-01-25 |
2013-05-20 |
ベントリア・バイオサイエンス |
タンパク質の生成を改善するための方法および組成物
|
|
US10233228B2
(en)
|
2010-04-09 |
2019-03-19 |
Albumedix Ltd |
Albumin derivatives and variants
|
|
RU2569745C2
(ru)
|
2010-06-08 |
2015-11-27 |
Пиерис АГ |
Мутеины липокалина слезы, связывающие альфа il-4 r
|
|
NZ606584A
(en)
|
2010-08-16 |
2014-10-31 |
Pieris Ag |
Binding proteins for hepcidin
|
|
CA2810844C
(en)
|
2010-09-07 |
2017-03-21 |
Dmi Acquisition Corp. |
Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
|
|
US9260492B2
(en)
|
2010-11-15 |
2016-02-16 |
Pieris Ag |
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
|
|
EP2646552B1
(en)
|
2010-12-02 |
2017-07-05 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 with affinity for ctla-4
|
|
PL221899B1
(pl)
|
2011-05-06 |
2016-06-30 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną |
Czysta albumina oraz sposób jej otrzymywania i detekcji
|
|
JP6247210B2
(ja)
|
2011-07-05 |
2017-12-13 |
アルブミディクス アクティーゼルスカブ |
アルブミン製剤及び用途
|
|
SG10201608087WA
(en)
|
2011-10-10 |
2016-11-29 |
Ampio Pharmaceuticals Inc |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
|
EP3721884A1
(en)
|
2011-10-10 |
2020-10-14 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease with da-dkp (= aspartyl-alanyl diketopiperazine)
|
|
CN103841974A
(zh)
|
2011-10-28 |
2014-06-04 |
安皮奥制药股份有限公司 |
鼻炎的治疗
|
|
EP2780364A2
(en)
|
2011-11-18 |
2014-09-24 |
Eleven Biotherapeutics, Inc. |
Proteins with improved half-life and other properties
|
|
ES2710384T3
(es)
|
2011-12-13 |
2019-04-24 |
Pieris Pharmaceuticals Gmbh |
Procedimientos para la prevención o el tratamiento de determinados trastornos mediante la inhibición de la unión de IL-4 y/o IL-13 a sus respectivos receptores
|
|
WO2013135896A1
(en)
|
2012-03-16 |
2013-09-19 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
|
WO2013174783A1
(en)
|
2012-05-23 |
2013-11-28 |
Pieris Ag |
Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
|
|
US20140031527A1
(en)
*
|
2012-07-27 |
2014-01-30 |
Csl Limited |
Method for polishing albumin
|
|
MX2015005363A
(es)
|
2012-11-08 |
2015-11-06 |
Novozymes Biopharma Dk As |
Variantes de albumina.
|
|
WO2014076321A1
(en)
|
2012-11-19 |
2014-05-22 |
Pieris Ag |
Novel specific-binding polypeptides and uses thereof
|
|
US20140186447A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
JP6128677B2
(ja)
*
|
2013-02-05 |
2017-05-17 |
公立大学法人大阪市立大学 |
神経細胞の遊走障害を伴う疾患の判定方法及びその利用
|
|
HK1213194A1
(zh)
|
2013-03-14 |
2016-06-30 |
Daiichi Sankyo Co., Ltd. |
用於新型的结合蛋白质pcsk9
|
|
CA2906864A1
(en)
|
2013-03-15 |
2014-09-18 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
CN103694343B
(zh)
*
|
2013-12-26 |
2016-05-25 |
扬州艾迪生物科技有限公司 |
一种从尿液中制备人血白蛋白的方法
|
|
EP3094650A2
(en)
|
2014-01-13 |
2016-11-23 |
Pieris Pharmaceuticals GmbH |
Multi-specific polypeptide useful for localized tumor immunomodulation
|
|
ES2975172T1
(es)
*
|
2014-04-30 |
2024-07-03 |
Novo Nordisk As |
Métodos para la purificación de proteínas usando ácido caprílico
|
|
SG11201609274SA
(en)
|
2014-05-22 |
2016-12-29 |
Pieris Pharmaceuticals Gmbh |
Novel specific-binding polypeptides and uses thereof
|
|
CA2958080A1
(en)
|
2014-08-18 |
2016-02-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
CN104628830A
(zh)
*
|
2015-01-23 |
2015-05-20 |
深圳康泰生物制品股份有限公司 |
重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗
|
|
JP6839087B2
(ja)
|
2015-01-28 |
2021-03-03 |
ピエリス ファーマシューティカルズ ゲーエムベーハー |
血管新生に特異的な新規のタンパク質
|
|
TN2017000348A1
(en)
|
2015-02-18 |
2019-01-16 |
Sanofi Sa |
Novel proteins specific for pyoverdine and pyochelin
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
KR20170138574A
(ko)
|
2015-05-04 |
2017-12-15 |
피어이스 파마슈티컬즈 게엠베하 |
항암 융합 폴리펩타이드
|
|
KR102734408B1
(ko)
|
2015-05-04 |
2024-11-27 |
피어이스 파마슈티컬즈 게엠베하 |
Cd137에 특이적인 신규한 단백질
|
|
MX390894B
(es)
|
2015-05-18 |
2025-03-21 |
Pieris Pharmaceuticals Gmbh |
Polipéptido de fusión anti-cáncer.
|
|
AU2016262838B2
(en)
|
2015-05-18 |
2020-10-08 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for Glypican-3 (GPC3)
|
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
|
EP3115371A1
(en)
|
2015-07-07 |
2017-01-11 |
Sanofi |
Fusion molecules
|
|
KR20180029238A
(ko)
|
2015-07-15 |
2018-03-20 |
피어이스 파마슈티컬즈 게엠베하 |
Lag-3에 특이적인 신규 단백질
|
|
WO2017029407A1
(en)
|
2015-08-20 |
2017-02-23 |
Albumedix A/S |
Albumin variants and conjugates
|
|
FR3040882A1
(fr)
*
|
2015-09-10 |
2017-03-17 |
Lab Francais Du Fractionnement |
Composition liquide d'albumine humaine a usage therapeutique
|
|
CN108699162A
(zh)
|
2015-11-30 |
2018-10-23 |
皮里斯澳大利亚有限公司 |
新型抗血管生成融合多肽
|
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|
|
JP7146637B2
(ja)
|
2015-12-22 |
2022-10-04 |
アルブミディクス リミティド |
改善されたタンパク質発現株
|
|
EP3394243A1
(en)
|
2015-12-22 |
2018-10-31 |
Albumedix Ltd. |
Improved protein expression strains
|
|
KR102050852B1
(ko)
*
|
2016-03-11 |
2019-12-03 |
주식회사 스템온 |
세포 리프로그래밍 장치
|
|
SG11201901081XA
(en)
*
|
2016-08-17 |
2019-03-28 |
Boehringer Ingelheim Int |
Process for the preparation of highly concentrated liquid formulations containing biomolecules
|
|
KR102662031B1
(ko)
|
2016-10-04 |
2024-05-03 |
알부메딕스 리미티드 |
재조합 효모-유래 혈청 알부민의 용도
|
|
WO2018087108A1
(en)
|
2016-11-09 |
2018-05-17 |
Pieris Pharmaceuticals Gmbh |
Proteins specific for cd137
|
|
WO2018134274A1
(en)
|
2017-01-18 |
2018-07-26 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding affinity for lag-3
|
|
US11427613B2
(en)
*
|
2017-03-16 |
2022-08-30 |
Evolve Biologics Inc. |
Method for purification of albumin
|
|
JP7282693B2
(ja)
|
2017-06-20 |
2023-05-29 |
アルブミディクス リミティド |
改良されたタンパク質発現株
|
|
CN110563833A
(zh)
*
|
2018-06-06 |
2019-12-13 |
中国计量科学研究院 |
一种人血白蛋白标准物质原料的制备方法及其产品和应用
|
|
CA3100119A1
(en)
|
2018-07-31 |
2020-02-06 |
Pieris Pharmaceuticals Gmbh |
Fusion protein specific for cd137 and pd-l1
|
|
CN109734796B
(zh)
*
|
2019-02-01 |
2022-04-15 |
广州蕊特生物科技有限公司 |
一种从溶血血清中分离白蛋白的工艺
|
|
CN109776673B
(zh)
*
|
2019-02-20 |
2022-03-29 |
天津理工大学 |
一种适合中试量产的高纯度牛血清白蛋白纯化工艺
|
|
MX2021010039A
(es)
|
2019-02-26 |
2021-09-21 |
Pieris Pharmaceuticals Gmbh |
Novedosas proteinas de fusion especificas para cd137 y gpc3.
|
|
CN110229229A
(zh)
*
|
2019-07-10 |
2019-09-13 |
甘肃养泰和生物科技有限公司 |
一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用
|
|
JP7832108B2
(ja)
|
2019-10-28 |
2026-03-17 |
アブラクシス バイオサイエンス， エルエルシー |
アルブミンおよびラパマイシンの医薬組成物
|
|
AU2021285201A1
(en)
|
2020-06-05 |
2022-11-24 |
Pieris Pharmaceuticals Gmbh |
Multimeric immunomodulator targeting 4-1BB
|
|
US12161777B2
(en)
|
2020-07-02 |
2024-12-10 |
Davol Inc. |
Flowable hemostatic suspension
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
|
AU2021326232A1
(en)
*
|
2020-08-11 |
2023-04-13 |
Shenzhen Protgen Ltd. |
Young and undamaged human serum albumin improves longevity of human
|
|
WO2022089639A1
(zh)
|
2020-10-30 |
2022-05-05 |
深圳普罗吉医药科技有限公司 |
人血清白蛋白在治疗疾病中的应用
|
|
WO2022120547A1
(zh)
|
2020-12-08 |
2022-06-16 |
通化安睿特生物制药股份有限公司 |
纯化重组蛋白的方法
|
|
CN112592399B
(zh)
*
|
2020-12-15 |
2024-04-12 |
甘肃养泰和生物科技有限公司 |
一种从牛血清中分离牛血清白蛋白的制备方法及装置
|
|
EP4267210A1
(en)
|
2020-12-28 |
2023-11-01 |
Davol Inc. |
Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
|
|
EP4320141A1
(en)
|
2021-04-08 |
2024-02-14 |
Pieris Pharmaceuticals GmbH |
Novel lipocalin muteins specific for connective tissue growth factor (ctgf)
|
|
WO2022243341A1
(en)
|
2021-05-18 |
2022-11-24 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding affinity for ox40
|
|
CN113735963A
(zh)
*
|
2021-09-10 |
2021-12-03 |
山东健通生物科技有限公司 |
一种重组人血清白蛋白纯化过程去除色素的方法
|
|
CN114316088B
(zh)
*
|
2021-12-22 |
2022-09-09 |
中国水产科学研究院黄海水产研究所 |
亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用
|
|
KR20250071257A
(ko)
|
2022-09-21 |
2025-05-21 |
씨젠 인크. |
Cd137 및 cd228에 특이적인 신규한 융합 단백질
|
|
CN115677848A
(zh)
|
2022-10-24 |
2023-02-03 |
通化安睿特生物制药股份有限公司 |
一种制备高纯度高稳定性蛋白质的方法
|
|
CN115763878A
(zh)
*
|
2022-11-24 |
2023-03-07 |
大连融科储能技术发展有限公司 |
一种抑制锌铁液流电池水跨膜迁移或渗透的方法
|
|
CN116120392B
(zh)
*
|
2023-04-18 |
2023-08-01 |
上海健士拜生物科技有限公司 |
聚体蛋白的纯化方法
|
|
WO2025175123A1
(en)
|
2024-02-16 |
2025-08-21 |
Seagen Inc. |
Methods of treating cancer using fusion proteins specific for cd137 and cd228
|
|
WO2026074121A1
(en)
|
2024-10-02 |
2026-04-09 |
Sartorius Albumedix Limited |
Albumin formulations and uses thereof
|